US Patent Issued to Takeda Pharmaceutical on Sept. 16 for "Monoclonal antibody inhibitor of Factor XIIa" (Massachusetts, New York Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,866, issued on Sept. 16, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaki, Japan).

"Monoclonal antibody inhibitor of Factor XIIa" was invented by Shauna Mason (Arlington, Mass.), Jon A. Kenniston (Hingham, Mass.), Andrew Nixon (Hanover, Mass.), Daniel J. Sexton (Melrose, Mass.), Stephen R. Comeau (Avon, N.Y.) and Burt Adelman (Concord, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular ...